Management of Parkinson’s disease
You must score at least 70% in this module to pass. Ensure you have read ‘Management of Parkinson’s disease’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
How much dopaminergic cell activity needs to be lost before Parkinson’s disease symptoms develop?
CorrectIncorrect - Question 2 of 15
2. Question
Which of the following is a risk factor for developing idiopathic Parkinson’s disease?
CorrectIncorrect - Question 3 of 15
3. Question
What proportion of the population with Parkinson’s disease are aged 50–89 years?
CorrectIncorrect - Question 4 of 15
4. Question
Parkinson’s disease is a chronic neurodegenerative condition predominantly caused by loss of dopamine containing cells in which part of the brain?
CorrectIncorrect - Question 5 of 15
5. Question
Who is the most appropriate person to diagnose Parkinson’s disease?
CorrectIncorrect - Question 6 of 15
6. Question
Which of the following drugs could cause Parkinsonian side effects?
CorrectIncorrect - Question 7 of 15
7. Question
Which of the following is always part of the diagnostic criteria for Parkinson’s disease?
CorrectIncorrect - Question 8 of 15
8. Question
Which of the below is an early symptoms of Parkinson’s disease?
CorrectIncorrect - Question 9 of 15
9. Question
Which of the following is a dopamine agonist?
CorrectIncorrect - Question 10 of 15
10. Question
Levodopa is normally combined with carbidopa or benserazide – what is the reason for this?
CorrectIncorrect - Question 11 of 15
11. Question
Which of the following non-motor symptoms can affect dopaminergic therapy response?
CorrectIncorrect - Question 12 of 15
12. Question
Which of the following is a side effect or complication more commonly associated with dopamine agonists, compared with levodopa?
CorrectIncorrect - Question 13 of 15
13. Question
Which one of the following statements is true?
CorrectIncorrect - Question 14 of 15
14. Question
Which of the following antipsychotic medications can be used to treat the psychotic symptoms sometimes associated with Parkinson’s disease?
CorrectIncorrect - Question 15 of 15
15. Question
Both pharmacological and non-pharmacological methods can be used to manage drooling of saliva in patients with Parkinson’s disease. What is the first-line treatment?
CorrectIncorrect